Lupin has received approval from the Food and Drug Administration for risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial and 50 mg per vial, single-dose vials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback